aspirin has been researched along with Hip Fractures in 56 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluates the efficacy and safety of rivaroxaban versus aspirin in prevention of venous thromboembolism (VTE) following total hip (THA) or knee arthroplasty (TKA) or hip fracture surgery." | 9.12 | Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis. ( Dai, Z; Hu, B; Hu, M; Jiang, L; Tang, H; Yu, J, 2021) |
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 9.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| "The study objective was to determine the relative efficacy and safety of a low-molecular-weight heparinoid (Orgaran) compared with aspirin for the prevention of postoperative venous thromboembolism in patients undergoing surgery for fractured hips." | 9.08 | Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. ( Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG, 1996) |
| "To compare venous thromboembolism (VTE) and bleeding rates in adult patients receiving aspirin versus anticoagulants after major lower extremity orthopedic surgery." | 8.90 | Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis. ( Chiang, WH; Drescher, FS; Larson, RJ; Lee, A; Morrison, DH; Sirovich, BE, 2014) |
| "To compare the efficacy and safety of aspirin with rivaroxaban following treatment with enoxaparin for prevention of venous thromboembolism (VTE) after hip fracture surgery (HFS)." | 7.91 | Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery. ( Huang, Q; Shen, B; Si, HB; Xing, SX; Zeng, Y; Zhou, ZK, 2019) |
| "In patients with extremity fractures that had been treated operatively or with any pelvic or acetabular fracture, thromboprophylaxis with aspirin was noninferior to low-molecular-weight heparin in preventing death and was associated with low incidences of deep-vein thrombosis and pulmonary embolism and low 90-day mortality." | 5.69 | Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. ( Bosse, MJ; Carlini, AR; Castillo, RC; Degani, Y; Firoozabadi, R; Frey, KP; Goldhaber, SZ; Haut, ER; Marvel, D; O'Hara, NN; O'Toole, RV; Obremskey, W; Scharfstein, DO; Slobogean, GP; Stein, DM; Sudini, K; Taylor, TJ, 2023) |
| "Aspirin was not associated with a significantly higher risk of hidden blood loss (aspirin group; median 598 mL [410-783 mL] vs control group; median 556 ml [321-741 mL], p = 0." | 5.62 | Retrospective high volume comparative study suggests that patients on aspirin could have immediate surgery for hip fractures without significant blood loss. ( Ito, Y; Kanazawa, T; Ohmori, T; Tada, K; Toda, K; Yagata, Y, 2021) |
| "To evaluates the efficacy and safety of rivaroxaban versus aspirin in prevention of venous thromboembolism (VTE) following total hip (THA) or knee arthroplasty (TKA) or hip fracture surgery." | 5.12 | Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis. ( Dai, Z; Hu, B; Hu, M; Jiang, L; Tang, H; Yu, J, 2021) |
| "Among the patients with hip fracture, allocation to aspirin produced proportional reductions in pulmonary embolism of 43% (95% CI 18-60; p=0." | 5.09 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. ( , 2000) |
| "The study objective was to determine the relative efficacy and safety of a low-molecular-weight heparinoid (Orgaran) compared with aspirin for the prevention of postoperative venous thromboembolism in patients undergoing surgery for fractured hips." | 5.08 | Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. ( Geerts, WH; Gent, M; Ginsberg, JS; Hirsh, J; Jay, RM; Leclerc, J; Levine, MN; Neemeh, JA; Powers, PJ; Turpie, AG, 1996) |
| "To compare venous thromboembolism (VTE) and bleeding rates in adult patients receiving aspirin versus anticoagulants after major lower extremity orthopedic surgery." | 4.90 | Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis. ( Chiang, WH; Drescher, FS; Larson, RJ; Lee, A; Morrison, DH; Sirovich, BE, 2014) |
| "Bone fractures are a global public health concern, yet no thorough investigation of low-dose aspirin usage to prevent fractures in the elderly has been conducted." | 4.31 | NHANES cross sectional study of aspirin and fractures in the elderly. ( Abbas, KS; Abouainain, Y; Ahmad, EMS; Albuni, MK; Battikh, E; El-Sakka, AA; Elkalagi, NKH; Hafez, W; Lee, KY; Rakab, A; Sawaf, B; Swed, S, 2023) |
| "One thousand four hundred forty-two geriatric (ages 60-105 years) patients undergoing isolated primary intramedullary fixation of nonpathologic extracapsular hip fractures from 2009 to 2018 including 657 taking an antiplatelet drug alone (including aspirin), 99 taking warfarin alone, 37 taking a direct oral anticoagulant (DOAC) alone, 59 taking an antiplatelet drug and an anticoagulant, and 590 taking neither." | 4.31 | Full Reversal of Anticoagulants Before Cephalomedullary Fixation of Geriatric Hip Fractures May Not Be Necessary. ( Ahn, J; Hake, ME; Maturana, C; Perdue, AM; Schaffer, NE; Singh, M, 2023) |
| " The incidence of VTE and hematoma formation was evaluated and compared between patients who received aspirin versus enoxaparin or heparin." | 4.12 | Does Aspirin Provide Adequate Chemoprophylaxis for Venous Thromboembolic Events in Operative Pelvic and Acetabular Fractures? ( Du, JY; Metcalf, KB; Ochenjele, G, 2022) |
| "To compare the efficacy and safety of aspirin with rivaroxaban following treatment with enoxaparin for prevention of venous thromboembolism (VTE) after hip fracture surgery (HFS)." | 3.91 | Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery. ( Huang, Q; Shen, B; Si, HB; Xing, SX; Zeng, Y; Zhou, ZK, 2019) |
| " The case was complicated due to a history of aspirin usage, marked obesity, and thrombocytopenia." | 3.67 | Femoral artery laceration complicating an intertrochanteric hip fracture: a multi-disciplinary therapeutic problem. ( Chmell, S; Haid, S; Milewski, S; Moss, GD; Pillars, JR, 1985) |
| "Proximal vein thrombosis or pulmonary embolism occurred in 6 patients (9." | 2.66 | A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. ( Gent, M; Hirsh, J; Jay, RM; Julian, DH; Levine, M; Powers, PJ; Turpie, AG, 1989) |
| " The purpose of this study is to quantify the complication rate associated with FICB in patients who are actively taking prescribed anticoagulant and/or antiplatelet medications prior to injury and identify factors that may predispose patients to an adverse event." | 1.72 | The safety of continuous fascia iliaca block in patients with hip fracture taking pre-injury anticoagulant and/or antiplatelet medications. ( Barletta, JF; Dzandu, JK; Mangram, AJ; Montanarella, PD; Prokuski, LJ; Shirah, GR; Sucher, JF, 2022) |
| "Aspirin was not associated with a significantly higher risk of hidden blood loss (aspirin group; median 598 mL [410-783 mL] vs control group; median 556 ml [321-741 mL], p = 0." | 1.62 | Retrospective high volume comparative study suggests that patients on aspirin could have immediate surgery for hip fractures without significant blood loss. ( Ito, Y; Kanazawa, T; Ohmori, T; Tada, K; Toda, K; Yagata, Y, 2021) |
| "The current rates of deep vein thrombosis (DVT) and pulmonary embolism (PE) at our institution following hip or knee arthroplasty or hip fracture surgery are 1." | 1.56 | Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit. ( Andrew, P; Farrington, B; Lawes, CM; Merriman, E; Millar, JS; Misur, P; Walker, M, 2020) |
| "The rate of postoperative complications has significantly increased annually only in HFS: VTE (P=0." | 1.46 | Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data. ( Ahn, H; Kim, S; Park, JH; Shin, SA; Won, CW, 2017) |
| " It appears from this study that in these cases prophylaxis against venous thromboembolism using aspirin in a dosage of 600 mg bid is ineffective." | 1.26 | Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur. ( Channon, GM; Wiley, AM, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (10.71) | 18.7374 |
| 1990's | 7 (12.50) | 18.2507 |
| 2000's | 19 (33.93) | 29.6817 |
| 2010's | 13 (23.21) | 24.3611 |
| 2020's | 11 (19.64) | 2.80 |
| Authors | Studies |
|---|---|
| Metcalf, KB | 1 |
| Du, JY | 1 |
| Ochenjele, G | 1 |
| Sucher, JF | 1 |
| Barletta, JF | 1 |
| Shirah, GR | 1 |
| Prokuski, LJ | 1 |
| Montanarella, PD | 1 |
| Dzandu, JK | 1 |
| Mangram, AJ | 1 |
| O'Toole, RV | 1 |
| Stein, DM | 1 |
| O'Hara, NN | 1 |
| Frey, KP | 1 |
| Taylor, TJ | 1 |
| Scharfstein, DO | 1 |
| Carlini, AR | 1 |
| Sudini, K | 1 |
| Degani, Y | 1 |
| Slobogean, GP | 1 |
| Haut, ER | 1 |
| Obremskey, W | 1 |
| Firoozabadi, R | 1 |
| Bosse, MJ | 1 |
| Goldhaber, SZ | 1 |
| Marvel, D | 1 |
| Castillo, RC | 1 |
| Swed, S | 1 |
| El-Sakka, AA | 1 |
| Abouainain, Y | 1 |
| Lee, KY | 1 |
| Sawaf, B | 1 |
| Albuni, MK | 1 |
| Battikh, E | 1 |
| Ahmad, EMS | 1 |
| Elkalagi, NKH | 1 |
| Abbas, KS | 1 |
| Hafez, W | 1 |
| Rakab, A | 1 |
| Maturana, C | 1 |
| Singh, M | 1 |
| Perdue, AM | 1 |
| Ahn, J | 1 |
| Hake, ME | 1 |
| Schaffer, NE | 1 |
| Poacher, AT | 1 |
| Hoskins, HC | 1 |
| Protty, MB | 1 |
| Pettit, R | 1 |
| Johansen, A | 1 |
| Huang, Q | 1 |
| Xing, SX | 1 |
| Zeng, Y | 1 |
| Si, HB | 1 |
| Zhou, ZK | 1 |
| Shen, B | 1 |
| Sugiyama, T | 1 |
| Millar, JS | 1 |
| Lawes, CM | 1 |
| Farrington, B | 1 |
| Andrew, P | 1 |
| Misur, P | 1 |
| Merriman, E | 1 |
| Walker, M | 1 |
| Ohmori, T | 1 |
| Toda, K | 1 |
| Kanazawa, T | 1 |
| Tada, K | 1 |
| Yagata, Y | 1 |
| Ito, Y | 1 |
| Hu, B | 1 |
| Jiang, L | 1 |
| Tang, H | 1 |
| Hu, M | 1 |
| Yu, J | 1 |
| Dai, Z | 1 |
| Wang, R | 1 |
| Wang, X | 1 |
| Tong, P | 1 |
| Kim, S | 1 |
| Ahn, H | 1 |
| Shin, SA | 1 |
| Park, JH | 1 |
| Won, CW | 1 |
| Lin, SY | 1 |
| Huang, HT | 1 |
| Chou, SH | 1 |
| Ho, CJ | 1 |
| Liu, ZM | 1 |
| Chen, CH | 1 |
| Lu, CC | 1 |
| Drescher, FS | 1 |
| Sirovich, BE | 1 |
| Lee, A | 1 |
| Morrison, DH | 1 |
| Chiang, WH | 1 |
| Larson, RJ | 1 |
| Sood, A | 1 |
| Trinh, QD | 1 |
| Li, T | 1 |
| Lv, M | 1 |
| Li, Q | 1 |
| Lowe, G | 1 |
| Estilita, J | 1 |
| Alonso, FM | 1 |
| Brasil, JS | 1 |
| Baptista, MS | 1 |
| Voelker, R | 1 |
| Struijk-Mulder, MC | 1 |
| Ettema, HB | 1 |
| Verheyen, CC | 1 |
| Büller, HR | 1 |
| Sobieraj-Teague, M | 1 |
| Eikelboom, JW | 1 |
| Hirsh, J | 3 |
| Chechik, O | 1 |
| Thein, R | 1 |
| Fichman, G | 1 |
| Haim, A | 1 |
| Tov, TB | 1 |
| Steinberg, EL | 1 |
| Scholl, S | 1 |
| Dellon, ES | 1 |
| Shaheen, NJ | 1 |
| Kragh, AM | 1 |
| Waldén, M | 1 |
| Apelqvist, A | 1 |
| Wagner, P | 1 |
| Atroshi, I | 1 |
| Ji, HM | 1 |
| Lee, YK | 1 |
| Ha, YC | 1 |
| Kim, KC | 1 |
| Koo, KH | 1 |
| Collinge, CA | 1 |
| Kelly, KC | 1 |
| Little, B | 1 |
| Weaver, T | 1 |
| Schuster, RD | 1 |
| Wordsworth, DR | 1 |
| Halsey, T | 1 |
| Griffiths, R | 1 |
| Parker, MJ | 1 |
| Kennedy, MT | 1 |
| Roche, S | 1 |
| Fleming, SM | 1 |
| Lenehan, B | 1 |
| Curtin, W | 1 |
| Colwell, CW | 1 |
| Grant, PJ | 1 |
| Jaffer, AK | 1 |
| Jeong, GK | 1 |
| Gruson, KI | 1 |
| Egol, KA | 1 |
| Aharonoff, GB | 1 |
| Karp, AH | 1 |
| Zuckerman, JD | 2 |
| Koval, KJ | 1 |
| Harty, JA | 1 |
| McKenna, P | 1 |
| Moloney, D | 1 |
| D'Souza, L | 1 |
| Masterson, E | 1 |
| Purushothaman, B | 1 |
| Alho, A | 1 |
| Stangeland, L | 1 |
| Røttingen, J | 1 |
| Wiig, JN | 1 |
| Monreal, M | 1 |
| Lafoz, E | 1 |
| Roca, J | 1 |
| Granero, X | 1 |
| Soler, J | 1 |
| Salazar, X | 1 |
| Olazabal, A | 1 |
| Bergqvist, D | 1 |
| Feldman, DS | 1 |
| Walters, I | 1 |
| Sakales, SR | 1 |
| Warwick, DJ | 1 |
| Gent, M | 2 |
| Ginsberg, JS | 1 |
| Powers, PJ | 2 |
| Levine, MN | 1 |
| Geerts, WH | 1 |
| Jay, RM | 2 |
| Leclerc, J | 1 |
| Neemeh, JA | 1 |
| Turpie, AG | 2 |
| Bauer, DC | 1 |
| Orwoll, ES | 1 |
| Fox, KM | 1 |
| Vogt, TM | 1 |
| Lane, NE | 1 |
| Hochberg, MC | 1 |
| Stone, K | 1 |
| Nevitt, MC | 1 |
| Nettleman, MD | 1 |
| Alsip, J | 1 |
| Schrader, M | 1 |
| Schulte, M | 1 |
| Sors, H | 1 |
| Meyer, G | 1 |
| Henley, E | 1 |
| Mahé, I | 1 |
| Bergmann, JF | 1 |
| Mahé, E | 1 |
| Caulin, C | 1 |
| Parker, M | 1 |
| Thomas, DP | 2 |
| Grace, DL | 1 |
| McCahill, JP | 1 |
| Carrington, RW | 1 |
| Skinner, JA | 1 |
| Channon, GM | 1 |
| Wiley, AM | 1 |
| Yett, HS | 1 |
| Skillman, JJ | 1 |
| Salzman, EW | 1 |
| Orthner, E | 1 |
| Hertz, H | 1 |
| Kwasny, O | 1 |
| Maier, R | 1 |
| Zekert, F | 1 |
| Schemper, M | 1 |
| Höfer, R | 1 |
| Bergmann, H | 1 |
| Havlick, E | 1 |
| Wohlzogen, FX | 1 |
| Pini, M | 1 |
| Spadini, E | 1 |
| Carluccio, L | 1 |
| Giovanardi, C | 1 |
| Magnani, E | 1 |
| Ugolotti, U | 1 |
| Uggeri, E | 1 |
| Julian, DH | 1 |
| Levine, M | 1 |
| Moss, GD | 1 |
| Chmell, S | 1 |
| Pillars, JR | 1 |
| Haid, S | 1 |
| Milewski, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients[NCT02774265] | Phase 3 | 329 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
DVT and how the diagnosis was made will be recorded. The number of events in participants in each arm will be compared to evaluate efficacy. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 5 |
| VTE Prophylaxis With Aspirin 81mg BID | 9 |
Bases on imaging obtained for symptoms. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 6 |
| VTE Prophylaxis With Aspirin 81mg BID | 2 |
Includes a greater than 2g/dL drop in hemoglobin, blood transfusion, hematoma evacuation, re-operation for a deep surgical site infection or minor procedure for bleeding and GI bleed (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 52 |
| VTE Prophylaxis With Aspirin 81mg BID | 53 |
5 reviews available for aspirin and Hip Fractures
| Article | Year |
|---|---|
Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Fracture Fix | 2021 |
Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fema | 2014 |
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Cast | 2010 |
When should prophylactic anticoagulation begin after a hip fracture?
Topics: Anticoagulants; Aspirin; Chemoprevention; Heparin; Hip Fractures; Humans; Risk Assessment; Risk Fact | 2006 |
Current concepts in venous thromboembolism and major lower limb orthopaedic surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement; Aspirin; Heparin, Low-Molecular- | 2002 |
13 trials available for aspirin and Hip Fractures
| Article | Year |
|---|---|
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.
Topics: Adult; Anticoagulants; Aspirin; Chemoprevention; Extremities; Fractures, Bone; Hemorrhage; Heparin, | 2023 |
[Comprehensive prophylaxis for deep venous thrombosis after proximal femur fractures in geriatric patients].
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Combined Modality Therapy; Female; Femoral Neck Fr | 2008 |
Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
Topics: Adult; Aspirin; Cost-Benefit Analysis; Female; Heparin; Hip Fractures; Humans; Male; Prospective Stu | 1984 |
Platelet count, antiplatelet therapy and pulmonary embolism--a prospective study in patients with hip surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage | 1995 |
Antiplatelet therapy to prevent thrombosis after hip fracture.
Topics: Aged; Aspirin; Drug Interactions; Heparin; Hip Fractures; Humans; Platelet Aggregation Inhibitors; P | 1995 |
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chondroitin Sulfates; | 1996 |
Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group.
Topics: Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Density; Female; Fractures, Bo | 1996 |
Place of aspirin in prophylaxis of venous thromboembolism.
Topics: Arthroplasty, Replacement, Hip; Aspirin; Dose-Response Relationship, Drug; Hip Fractures; Humans; Pl | 2000 |
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Aspirin; Cause of Death; Dose-Response Rela | 2000 |
The hazards of aspirin plus heparin.
Topics: Aspirin; Drug Therapy, Combination; Hemorrhage; Heparin; Hip Fractures; Humans; Thrombophlebitis; Wa | 1978 |
[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].
Topics: Aged; Aged, 80 and over; Aspirin; Bone Screws; Cause of Death; Dihydroergotamine; Drug Combinations; | 1990 |
Dextran/aspirin versus heparin/dihydroergotamine in preventing thrombosis after hip fractures.
Topics: Aged; Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Double-Blind Method; Drug Ther | 1985 |
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Female; Follow-Up Studies; Hemorr | 1989 |
38 other studies available for aspirin and Hip Fractures
| Article | Year |
|---|---|
Does Aspirin Provide Adequate Chemoprophylaxis for Venous Thromboembolic Events in Operative Pelvic and Acetabular Fractures?
Topics: Anticoagulants; Aspirin; Chemoprevention; Enoxaparin; Hematoma; Heparin; Hip Fractures; Humans; Pelv | 2022 |
The safety of continuous fascia iliaca block in patients with hip fracture taking pre-injury anticoagulant and/or antiplatelet medications.
Topics: Aged; Aged, 80 and over; Aspirin; Hip Fractures; Humans; Nerve Block; Platelet Aggregation Inhibitor | 2022 |
NHANES cross sectional study of aspirin and fractures in the elderly.
Topics: Aged; Aged, 80 and over; Aspirin; Bone Density; Cross-Sectional Studies; Female; Fractures, Bone; Hi | 2023 |
Full Reversal of Anticoagulants Before Cephalomedullary Fixation of Geriatric Hip Fractures May Not Be Necessary.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Cohort Studies; Hip Fractures; Humans; Platelet | 2023 |
The impact of adopting low-molecular-weight heparin in place of aspirin as routine thromboprophylaxis for patients with hip fracture.
Topics: Anticoagulants; Aspirin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Postoperative Complic | 2023 |
Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Ther | 2019 |
Proton Pump Inhibitor Therapy and Fracture Risk: Discrepancy of Results Between Observational and Interventional Studies.
Topics: Aspirin; Hip Fractures; Humans; Proton Pump Inhibitors; Research; Rivaroxaban | 2020 |
Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2020 |
Retrospective high volume comparative study suggests that patients on aspirin could have immediate surgery for hip fractures without significant blood loss.
Topics: Aged; Aspirin; Blood Loss, Surgical; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Retrosp | 2021 |
Comment on "Retrospective high volume comparative study suggests that patients on aspirin could have immediate surgery for hip fractures without significant blood loss".
Topics: Aspirin; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Retrospective Studies | 2021 |
Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2017 |
The Safety of Continuing Antiplatelet Medication Among Elderly Patients Undergoing Urgent Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Blood Transfusion; Dipyridamole; Drug Therap | 2019 |
Perioperative aspirin: to give or not to give?
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Female; Fibrinolytic Agents; H | 2014 |
Thromboprophylaxis for patients at high risk of VTE.
Topics: Anticoagulants; Aspirin; Heparin; Hip Fractures; Humans; Practice Guidelines as Topic; Pulmonary Emb | 2008 |
[Intradural block in essential thrombocytosis].
Topics: Aged, 80 and over; Anesthesia, Spinal; Aspirin; Female; Fracture Fixation, Internal; Hematoma, Epidu | 2009 |
Common drugs can harm elderly patients.
Topics: Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Cerebral Hemorrhage; Drug Therapy, Combinati | 2009 |
How can we reduce disagreement among guidelines for venous thromboembolism prevention?
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Cast | 2010 |
The effect of clopidogrel and aspirin on blood loss in hip fracture surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Drug Therapy | 2011 |
Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
Topics: Adenocarcinoma; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aspirin; Barrett Esop | 2011 |
Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Cohort Studies; Dose-Response Relationship, | 2011 |
Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Hip Fractures; Humans; | 2011 |
The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; | 2012 |
Clopidogrel has no effect on mortality from hip fracture.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Aspirin; Bl | 2013 |
The association between aspirin and blood loss in hip fracture patients.
Topics: Aged; Aged, 80 and over; Aspirin; Bleeding Time; Blood Loss, Surgical; Blood Transfusion; Case-Contr | 2006 |
Thromboprophylaxis in orthopedic surgery.
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, | 2006 |
Thromboprophylaxis after hip fracture: evaluation of 3 pharmacologic agents.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Dextrans; Enoxaparin; Female; Fibrinolytic Agents; | 2007 |
Anti-platelet agents and surgical delay in elderly patients with hip fractures.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Female; Hip Fractures; Humans; Male; Platelet Aggrega | 2007 |
Anti-platelet agents and surgical delay in elderly patients with hip fractures.
Topics: Aged; Aspirin; Bleeding Time; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Hip Fractures; Hum | 2008 |
Clinical efficacy of aspirin and dextran for thromboprophylaxis in geriatric hip fracture patients.
Topics: Aged; Aspirin; Dextrans; Female; Hip Fractures; Humans; Male; Prospective Studies; Pulmonary Embolis | 1993 |
Predictors of mortality after acute hip fracture.
Topics: Aged; Aged, 80 and over; Aspirin; Comorbidity; Female; Hip Fractures; Hospital Mortality; Humans; Io | 1996 |
Can low-dose aspirin prevent thromboembolic phenomena in patients undergoing surgery for hip fracture or elective arthroplasty?
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Cause of Death; Double-Blind Method; Follow-Up S | 2000 |
PEP trial. Pulmonary Embolism Prevention.
Topics: Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Meta-Analysis as | 2000 |
PEP trial. Pulmonary Embolism Prevention.
Topics: Aspirin; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pulmonary | 2000 |
PEP trial. Pulmonary Embolism Prevention.
Topics: Aged; Arthroplasty, Replacement, Hip; Aspirin; Hip Fractures; Humans; Male; Myocardial Infarction; P | 2000 |
Thromboprophylaxis--which treatment for which patient?
Topics: Arthroplasty, Replacement, Hip; Aspirin; Chemoprevention; Fibrinolytic Agents; Hip Fractures; Humans | 2000 |
Prophylactic low-dose aspirin therapy in patients having hip-fracture surgery or elective arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Hip Fractu | 2001 |
Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur.
Topics: Aged; Aspirin; Female; Femoral Neck Fractures; Hip Fractures; Hip Prosthesis; Humans; Male; Middle A | 1979 |
Femoral artery laceration complicating an intertrochanteric hip fracture: a multi-disciplinary therapeutic problem.
Topics: Aged; Aspirin; Embolization, Therapeutic; Female; Femoral Artery; Hematoma; Hip Fractures; Humans; O | 1985 |